• BSE
  • NSE
    • {{d.cmpname}}
    • {{d.price}}
    • ({{d.PerChg}}%)
Market | Equity | Daily Market Tracker | IPO Synopsis
IPO SYNOPSIS
Glenmark Life Sciences Ltd
Registered Office:
Plot No. 170-172 Chandramouli,Industrial Est.Mohol Bazarpeth,
Solapur - 413213,
Maharashtra, India.
Initial public offer of 21,022,222 equity shares of face value of (Rs) 2 each ("equity shares") of Glenmark Life Sciences Limited ("Company" or "Issuer") for cash at a price of (Rs) 720 per equity share (including a share premium of (Rs) 718 per equity share) aggregating to (Rs) 1513.60 crores (the "offer") comprising a fresh issue of 14,722,222 equity shares aggregating to (Rs) 1060 crores (the "fresh issue") and an offer for sale of up to 6,300,000 equity shares by Glenmark Pharmaceuticals Limited ("Promoter Selling Shareholder") and such equity shares, The "offered shares") aggregating to (Rs) 453.60 crores (The "offer for sale"). The offer shall constitute 17.16% of the post-offer paid-up equity share capital of the company. The face value of equity shares is (Rs) 2 each. Offer Price : (Rs) 720 per Equity Share of face value of (Rs) 2 each. Anchor Investor offer price: (Rs) 720 per Equity share. The Offer Price is 360 times the face value.
Issue
Money Payable On
Opens On
Closes On
Application
Allotment
27-Jul-21
29-Jul-21
720.00-0.00
0.00-0.00
Minimum Application for shares in Nos : 20     Further Multiples of : 20
 
(Rs.Cr)
Lead Managers to the Issue
Project Cost
1060.00
BOB Capital Markets Ltd
Project Financed
1513.60
 
Post Issue
24.51
 
Issue Price
720.00
 
Projects
Payment of outstanding purchase consideration to the promoter for the spin-off of the API business from the promoter into the company pursuant to the Business Purchase agreement
Funding capital expenditure requirements
General corporate purposes
Promoted By
Glenmark Pharmaceuticals Ltd
Listing At
BSE
NSE
Registrar to the Issue
KFin Techologies Pvt Ltd
DB (International) Stock Brokers Limited: SEBI Reg. No.-INZ000179035 / CDSL : IN-DP-CDSL-266-2004 MCX-SX:INE 260643233/21500(CD)
Daga Commodities Private Limited: SEBI Reg. No. INZ000028833
Investor Grievances Email ID: compliance@dbonline.in & investors@dbonline.in
Copyright © 2016 All rights Reserved DB (International) Stock Brokers Ltd.     Designed, Developed and content powered by C-MOTS Infotech( ISO 9001:2015 certified )
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."         "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......................issued in the interest of investors."          "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Attention Investors ::
subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries